Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Neuropathy;Peripheral: early-phase trial registry
1 of 7 indexed Neuropathy;Peripheral trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 1 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Neuropathy;Peripheral: 7 US clinical trials tracked, 1 recruiting.
Neuropathy;Peripheral is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Bexion Pharmaceuticals, running 1 of these trials.
Enrollment posture brief
Registry condition neuropathyperipheral
OPEN 1 | RECR 14% | LATE 0 | EARLY 3 | RANK #2497 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adverse Drug Events (14% recruiting · 7 trials)
Neuropathy;Peripheral lists 1 open slots (14% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Neuropathy;Peripheral on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Neuropathy;Peripheral is recruiting below its size-band peers.
1 of 7 indexed trials (14.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Neuropathy;Peripheral trials is spread across many organizations.
Bexion Pharmaceuticals accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.
-
Most Neuropathy;Peripheral trials plan to enrol fewer than 100 people.
Median target enrolment is 24 among the 7 trials that report a genuine target (sentinel values excluded). 7 of those (100%) plan for fewer than 100 participants.
-
Neuropathy;Peripheral research is mostly interventional.
7 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
Clinical Efficacy of the Erchonia EVRL for Providing Temporary Relief of Idiopathic Peripheral Neuropathy Foot Pain
Erchonia Corporation
NCT06912646
The Effect of Low Frequency Soundwave Stimulation on Chemotherapy Induced Peripheral Neuropathy
Augusta University
NCT05980169
Exploring the Benefit of Neuromodulation in Treating Chemo-induced Peripheral Neuropathy Using Peripheral Neuropathy Markers (Meissner's Corpuscles and Epidermal Nerve Fiber Density) and Sensory Testing (Quantitative Sensory and Gait Testing): A Single Center Feasibility Study
M.D. Anderson Cancer Center
NCT06121232
ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy
Shayna Sarosiek, MD
NCT05065554
Exercise and Nutrition Interventions During Chemotherapy K07
University of Rochester
NCT03858153
BXQ-350 Pharmacokinetic/Pharmacodynamic Study in Cancer Patients
Bexion Pharmaceuticals
NCT05291286
Diffusion Tensor Imaging in Predicting Development of Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer (CIPN)
University of Arizona
NCT03365895
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Neuropathy;Peripheral records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Neuropathy;Peripheral trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Neuropathy;Peripheral page
7 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Neuropathy;Peripheral trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Bexion Pharmaceuticals sponsors the most Neuropathy;Peripheral trials on record, review their full trial history before evaluating a specific study. See Bexion Pharmaceuticals's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Neuropathy;Peripheral condition card totals 7 registered trials; most-linked intervention EXCAP Exercise; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.